APIMEDS PHARMACEUTICALS US I

Historical 13F Holders

Symbol
APUS
CUSIP
03771D102
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 03771D102 since 12/18/2024, newest first.

Filer % of Class Filed
Inscobee Inc. 13D/A Amendment 4
34.3% 5/7/2026
Event 5/7/2026
Inscobee Inc. 13D/A Amendment 3
34.3% 3/30/2026
Event 3/25/2026
Inscobee Inc. 13D/A Amendment 2
34.3% 3/20/2026
Event 3/20/2026
Ayrton Capital LLC 13G
10.0% 2/11/2026
Event 12/31/2025
Inscobee Inc. 13D/A Amendment 1
34.3% 1/26/2026
Event 12/1/2025
Inscobee Inc. 13D
37.9% 5/19/2025
Event 5/12/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 7 426 k $384 k
2026 Q1 6 449 k $803 k
2025 Q4 7 396 k $649 k
2025 Q3 9 400 k $712 k
2025 Q2 7 279 k $490 k